EGFR mutation in squamous cell carcinoma of the lung: does it carry the same connotation as in adenocarcinomas?

BACKGROUND: EGFR tyrosine kinase inhibitors (TKIs) have greatly improved the outcomes of EGFR mutation-positive adenocarcinomas of the lung. In contrast, the significance of EGFR mutation in metastatic squamous cell carcinoma (SCC) of the lung has been debated. METHODS: All patients with metastatic...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Onco Targets Ther
Asıl Yazarlar: Joshi, Amit, Zanwar, Saurabh, Noronha, Vanita, Patil, Vijay M, Chougule, Anuradha, Kumar, Rajiv, Janu, Amit, Mahajan, Abhishek, Kapoor, Akhil, Prabhash, Kumar
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Dove Medical Press 2017
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5378442/
https://ncbi.nlm.nih.gov/pubmed/28405166
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S125397
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller